Latest Insider Transactions at Moderna, Inc. (MRNA)
This section provides a real-time view of insider transactions for Moderna, Inc. (MRNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moderna, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moderna, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 03
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.56%
|
$0
$0.99 P/Share
|
|
Nov 02
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
8,893
-0.1%
|
$604,724
$68.02 P/Share
|
|
Nov 02
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.57%
|
$680,000
$68.02 P/Share
|
|
Nov 02
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.56%
|
$0
$0.99 P/Share
|
|
Nov 02
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-96.33%
|
$1,005,000
$67.49 P/Share
|
|
Nov 02
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+45.0%
|
$225,000
$15.68 P/Share
|
|
Oct 30
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.81%
|
$751,128
$68.96 P/Share
|
|
Oct 29
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$680,000
$68.39 P/Share
|
|
Oct 28
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Oct 28
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$612,000
$68.75 P/Share
|
|
Oct 26
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-72.3%
|
$1,050,000
$70.21 P/Share
|
|
Oct 26
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+45.0%
|
$225,000
$15.68 P/Share
|
|
Oct 26
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.09%
|
$350,000
$70.41 P/Share
|
|
Oct 23
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.05%
|
$773,220
$70.28 P/Share
|
|
Oct 23
2020
|
Stephen Hoge President |
BUY
Bona fide gift
|
Indirect |
151,933
+50.0%
|
-
|
|
Oct 23
2020
|
Stephen Hoge President |
SELL
Bona fide gift
|
Direct |
151,933
-7.95%
|
-
|
|
Oct 23
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.26%
|
$1,050,000
$70.41 P/Share
|
|
Oct 23
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.52%
|
$0
$0.99 P/Share
|
|
Oct 22
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$680,000
$68.58 P/Share
|
|
Oct 21
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Oct 21
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$639,000
$71.31 P/Share
|
|
Oct 21
2020
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
32,000
-48.34%
|
$2,240,000
$70.12 P/Share
|
|
Oct 21
2020
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
32,000
+49.47%
|
$448,000
$14.85 P/Share
|
|
Oct 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
8,455
-0.09%
|
$608,760
$72.05 P/Share
|
|
Oct 19
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-74.11%
|
$1,080,000
$72.52 P/Share
|
|
Oct 19
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+45.0%
|
$225,000
$15.68 P/Share
|
|
Oct 16
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.02%
|
$828,450
$75.17 P/Share
|
|
Oct 15
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$750,000
$75.48 P/Share
|
|
Oct 14
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Oct 14
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$711,000
$79.81 P/Share
|
|
Oct 13
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.16%
|
$1,170,000
$78.37 P/Share
|
|
Oct 13
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.52%
|
$0
$0.99 P/Share
|
|
Oct 12
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.09%
|
$370,000
$74.36 P/Share
|
|
Oct 12
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-61.81%
|
$1,110,000
$74.37 P/Share
|
|
Oct 12
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+45.0%
|
$225,000
$15.68 P/Share
|
|
Oct 12
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
8,219
-0.09%
|
$599,987
$73.61 P/Share
|
|
Oct 09
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.47%
|
$806,358
$73.26 P/Share
|
|
Oct 08
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$730,000
$73.5 P/Share
|
|
Oct 07
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Oct 07
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$639,000
$71.23 P/Share
|
|
Oct 05
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-70.34%
|
$1,050,000
$70.54 P/Share
|
|
Oct 05
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+45.0%
|
$225,000
$15.68 P/Share
|
|
Oct 05
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.52%
|
$690,000
$69.5 P/Share
|
|
Oct 05
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.51%
|
$0
$0.99 P/Share
|
|
Oct 02
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.58%
|
$773,220
$70.22 P/Share
|
|
Oct 02
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.52%
|
$670,000
$67.86 P/Share
|
|
Oct 02
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.51%
|
$0
$0.99 P/Share
|
|
Oct 01
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
18,481
-0.11%
|
$1,275,189
$69.57 P/Share
|
|
Sep 30
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Sep 30
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$648,000
$72.72 P/Share
|